168 related articles for article (PubMed ID: 31724785)
1. Significant association between high serum CCL5 levels and better disease-free survival of patients with early breast cancer.
Fujimoto Y; Inoue N; Morimoto K; Watanabe T; Hirota S; Imamura M; Matsushita Y; Katagiri T; Okamura H; Miyoshi Y
Cancer Sci; 2020 Jan; 111(1):209-218. PubMed ID: 31724785
[TBL] [Abstract][Full Text] [Related]
2. C-C motif chemokine ligand 5 and C-C chemokine receptor type 5: possible diagnostic application in breast cancer patients.
Dąbrowska E; Przylipiak A; Zajkowska M; Piskór BM; Borowik-Zaręba A; Ławicki S
Acta Biochim Pol; 2020 Nov; 67(4):539-449. PubMed ID: 33245226
[TBL] [Abstract][Full Text] [Related]
3. Preoperative serum chemokine (C-C motif) ligand 2 levels and prognosis in colorectal cancer.
Szczepanik AM; Siedlar M; Szura M; Kibil W; Brzuszkiewicz K; Brandt P; Kulig J
Pol Arch Med Wewn; 2015; 125(6):443-51. PubMed ID: 26020569
[TBL] [Abstract][Full Text] [Related]
4. C-C motif chemokine ligand 5 (CCL5) levels in gastric cancer patient sera predict occult peritoneal metastasis and a poorer prognosis.
Wang T; Wei Y; Tian L; Song H; Ma Y; Yao Q; Feng M; Wang Y; Gao M; Xue Y
Int J Surg; 2016 Aug; 32():136-42. PubMed ID: 27398691
[TBL] [Abstract][Full Text] [Related]
5. Stromal CCL5 Promotes Breast Cancer Progression by Interacting with CCR3 in Tumor Cells.
Yamaguchi M; Takagi K; Narita K; Miki Y; Onodera Y; Miyashita M; Sasano H; Suzuki T
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671956
[TBL] [Abstract][Full Text] [Related]
6. Serum VEGF-A and CCL5 levels as candidate biomarkers for efficacy and toxicity of regorafenib in patients with metastatic colorectal cancer.
Suenaga M; Mashima T; Kawata N; Wakatsuki T; Horiike Y; Matsusaka S; Dan S; Shinozaki E; Seimiya H; Mizunuma N; Yamaguchi K; Yamaguchi T
Oncotarget; 2016 Jun; 7(23):34811-23. PubMed ID: 27166185
[TBL] [Abstract][Full Text] [Related]
7. Gastric cancer cells exploit CD4+ cell-derived CCL5 for their growth and prevention of CD8+ cell-involved tumor elimination.
Sugasawa H; Ichikura T; Kinoshita M; Ono S; Majima T; Tsujimoto H; Chochi K; Hiroi S; Takayama E; Saitoh D; Seki S; Mochizuki H
Int J Cancer; 2008 Jun; 122(11):2535-41. PubMed ID: 18246596
[TBL] [Abstract][Full Text] [Related]
8. Serum chemokine ligand 5 (CCL5/RANTES) level might be utilized as a predictive marker of tumor behavior and disease prognosis in patients with gastric adenocarcinoma.
Sima AR; Sima HR; Rafatpanah H; Hosseinnezhad H; Ghaffarzadehgan K; Valizadeh N; Mehrabi Bahar M; Hakimi HR; Masoom A; Noorbakhsh A; Razavi Satvati N; Raziee HR
J Gastrointest Cancer; 2014 Dec; 45(4):476-80. PubMed ID: 25301002
[TBL] [Abstract][Full Text] [Related]
9. Plasma CCL5 promotes EMT-medicated epirubicin-resistance in locally advanced breast cancer.
Ma G; Huang H; Li M; Li L; Kong P; Zhu Y; Xia T; Wang S
Cancer Biomark; 2018; 22(3):405-415. PubMed ID: 29758926
[TBL] [Abstract][Full Text] [Related]
10. Host genotype and tumor phenotype of chemokine decoy receptors integrally affect breast cancer relapse.
Yu KD; Wang X; Yang C; Zeng XH; Shao ZM
Oncotarget; 2015 Sep; 6(28):26519-27. PubMed ID: 26314842
[TBL] [Abstract][Full Text] [Related]
11. Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes.
Imamura M; Morimoto T; Nomura T; Michishita S; Nishimukai A; Higuchi T; Fujimoto Y; Miyagawa Y; Kira A; Murase K; Araki K; Takatsuka Y; Oh K; Masai Y; Akazawa K; Miyoshi Y
World J Surg Oncol; 2018 Feb; 16(1):26. PubMed ID: 29433529
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and prognostic potential of serum angiopoietin-2 expression in human breast cancer.
Li P; He Q; Luo C; Qian L
Int J Clin Exp Pathol; 2015; 8(1):660-4. PubMed ID: 25755760
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of TRAIL-R3 and CCR-2 expression in tumor epithelial cells of patients with early breast cancer.
Labovsky V; Martinez LM; Davies KM; de Luján Calcagno M; García-Rivello H; Wernicke A; Feldman L; Matas A; Giorello MB; Borzone FR; Choi H; Howard SC; Chasseing NA
BMC Cancer; 2017 Apr; 17(1):280. PubMed ID: 28420351
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of expression of CCL5/RANTES receptors in patients with gastric cancer.
Sugasawa H; Ichikura T; Tsujimoto H; Kinoshita M; Morita D; Ono S; Chochi K; Tsuda H; Seki S; Mochizuki H
J Surg Oncol; 2008 Apr; 97(5):445-50. PubMed ID: 18297689
[TBL] [Abstract][Full Text] [Related]
15. Effects of CCL5 on the biological behavior of breast cancer and the mechanisms of its interaction with tumor‑associated macrophages.
An G; Wu F; Huang S; Feng L; Bai J; Gu S; Zhao X
Oncol Rep; 2019 Dec; 42(6):2499-2511. PubMed ID: 31578575
[TBL] [Abstract][Full Text] [Related]
16. CCL5 protein level: influence on breast cancer staging and lymph nodes commitment.
Derossi DR; Amarante MK; Guembarovski RL; de Oliveira CEC; Suzuki KM; Watanabe MAE; de Syllos Cólus IM
Mol Biol Rep; 2019 Dec; 46(6):6165-6170. PubMed ID: 31691056
[TBL] [Abstract][Full Text] [Related]
17. Stromal MCP-1 in mammary tumors induces tumor-associated macrophage infiltration and contributes to tumor progression.
Fujimoto H; Sangai T; Ishii G; Ikehara A; Nagashima T; Miyazaki M; Ochiai A
Int J Cancer; 2009 Sep; 125(6):1276-84. PubMed ID: 19479998
[TBL] [Abstract][Full Text] [Related]
18. Relationship between CCL5 and transforming growth factor-β1 (TGFβ1) in breast cancer.
Hartmann MC; Dwyer RM; Costello M; Potter SM; Curran C; Hennessy E; Newell J; Griffin DG; Kerin MJ
Eur J Cancer; 2011 Jul; 47(11):1669-75. PubMed ID: 21658938
[TBL] [Abstract][Full Text] [Related]
19. The chemokine CCL5 as a potential prognostic factor predicting disease progression in stage II breast cancer patients.
Yaal-Hahoshen N; Shina S; Leider-Trejo L; Barnea I; Shabtai EL; Azenshtein E; Greenberg I; Keydar I; Ben-Baruch A
Clin Cancer Res; 2006 Aug; 12(15):4474-80. PubMed ID: 16899591
[TBL] [Abstract][Full Text] [Related]
20. [Production and mechanism of CCL5 by macrophages in U14 cervical cancer-bearing mice during infection].
Ren H; Ren G; Sun L; Fan X; Wang Y; Li X
Zhonghua Fu Chan Ke Za Zhi; 2015 May; 50(5):367-73. PubMed ID: 26311457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
